Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the corporate would contemplate new talks with insurers concerning the checklist rates of Wegovy and copyright should they pledge to help keep the medicines on their own formularies. Sanders https://kethek.com/